Researcher

Sai-Kiang Lim received her PhD degree from SUNY, Buffalo, in 1992, before completing her postdoctoral training at Columbia University first as a Cooley’s Anemia Foundation Research Fellow (1992-94) and then a Leukemia Society of America Special Fellow (1994-96). She has since led independent research groups at the National University Medical Institute, the National University of Singapore (1996-2001), the A*STAR Genome Institute of Singapore (2002-2007) and the A*STAR Institute of Medical Biology (2007-2020). Lim is currently a Principal Investigator at the A*STAR Institute of Molecular & Cell Biology, with major research interests in natural and synthetic nano lipid vesicles with specific focus on their synthesis and purification, biochemical and biophysical characterisation, and diagnostic and therapeutic applications.
Related Articles
Tiny packages bring (cytokine) storm relief
16 Feb 2023A*STAR scientists decipher how a stem cell-based treatment stops the uncontrolled inflammation associated with severe
Call for rigor over COVID-19 exosome therapy
22 Jul 2020Stem cell experts recognize the potential of exosomes for treating COVID-19 pneumonia, but caution that